141 results on '"Gainor, J."'
Search Results
2. Granville Barker on Theatre: Selected Essays by Harley Granville Barker (review)
3. Global Ibsen: Performing Multiple Modernities (review)
4. Shaw and Feminisms: On Stage and Off ed. by D.A. Hadfield, Jean Reynolds (review)
5. Rutherford and Son by Githa Sowerby, and: The Stepmother by Githa Sowerby (review)
6. (Con)Fusing Theory and Practice: Bridging Scholarship and Performance in Theatre Pedagogy
7. Disclosing Intertextualities: The Stories, Plays, and Novels of Susan Glaspell , and: Susan Glaspell and the Anxiety of Expression: Language and Isolation in the Plays (review)
8. The Feminist Possibilities of Dramatic Realism by Patricia R. Schroeder (review)
9. Rethinking Feminism, Stanislavsky, and Performance
10. Glamour Addiction: Inside the American Ballroom Dance Industry (review)
11. Dancing Class: Gender, Ethnicity, and Social Divides in American Dance, 1890-1920 (review)
12. Ballroom, Boogie, Shimmy Sham, Shake: A Social and Popular Dance Reader (review)
13. Alison's House (review)
14. Jacques Copeau's "The Spirit in the Little Theatre": Contexts and Texts.
15. Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
16. 65O Phase III LEAP-008 study of lenvatinib plus pembrolizumab versus docetaxel for metastatic non-small cell lung cancer (NSCLC) that progressed on a PD-(L)1 inhibitor and platinum-containing chemotherapy
17. P1.12B.02 Mechanisms of Resistance to First-Line vs Later-Line Alectinib in ALK Fusion-Positive Non-Small Cell Lung Cancer.
18. MA15.09 LCMC3: Long-Term Disease-Free and Overall Survival and their Association with ctDNA after Neoadjuvant Atezolizumab for NSCLC
19. Real-World Patterns of Cranial Radiation Therapy Among Patients with Brain Metastases from Non-Small Cell Lung Cancer in the Era of CNS-Penetrant Tyrosine Kinase Inhibitors
20. Impact of Radiation Therapy on Long-Term Survival in Patients with KRAS-Mutant Stage IV NSCLC Treated with Immune Checkpoint Inhibitors
21. 68O Frequency of clinical acquired RAS-MAPK pathway resistance alterations in patients treated with KRASG12C inhibitors: An individual patient meta-analysis
22. 130P COM701 ± nivolumab: Preliminary results of antitumor activity from a phase I study in patients with metastatic NSCLC who have received prior PD-1/PD-L1 inhibitor
23. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
24. 41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)
25. 1170P Updated efficacy and safety data from the phase I/II ARROW study of pralsetinib in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC)
26. 984P Relationship between RET fusion partner and treatment outcomes in patients (pts) with non-small cell lung cancer (NSCLC) from the phase I/II ARROW study and real-world data (RWD)
27. Quantitative Evaluation of Normal Lung Density Changes in Non-Small Cell Lung Cancer Patients Treated With Radiotherapy and PD-1 Immune Checkpoint Inhibitors
28. SO-31 ASPEN-01: A phase 1 study of ALX148, a CD47 blocker, in combination with trastuzumab, ramucirumab and paclitaxel in patients with second-line HER2-positive advanced gastric or gastroesophageal junction cancer
29. P75.03 KEYNOTE-U01: A Phase 2 Umbrella Study of Investigational Agents Plus Pembrolizumab-Based Therapy for Advanced NSCLC
30. P14.26 Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status
31. OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study
32. Activité intracrânienne du selpercatinib (LOXO-292) chez les patients atteints d’un cancer bronchique non à petites cellules (CBNPC) exprimant le gène de fusion RET dans le cadre de l’essai LIBRETTO-001
33. OA05.02 Analysis of Resistance Mmechanisms to Pralsetinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) from the ARROW Study
34. The Feminist Possibilities of Dramatic Realism
35. OA14.04 Three-Year Outcomes with First-Line Pembrolizumab, in Patients with Non-Small-Cell Lung Cancer and A PD-L1 Tumor Proportion Score >90%.
36. Performing the Pilgrims: A Study of Ethnological Role-Playing at Plimoth Plantation
37. "ELEKTRA" BY EZRA POUND THE CLASSIC STAGE COMPANY, NOVEMBER 1-29, 1987
38. MA11.11 STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
39. MS01.01 Biological Mechanisms of Resistance
40. P2.04-23 Immune-Related Adverse Events: The Growing Pains of Immunooncology
41. P1.04-21 The Utility of PD-L1/CD8 Dual Immunohistochemistry for Prediction of Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
42. P3.07-012 Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases
43. P1.07-033 Differential Expression of Immune Inhibitory Markers in Association with the Immune Microenvironment in Resected Lung Adenocarcinomas
44. MA 07.07 Clinical Outcomes and ALK Resistance Mutations in ALK+ Non-Small Cell Lung Cancer According to EML4-ALK Variant
45. MA 05.02 STK11/LKB1 Loss of Function Genomic Alterations Predict Primary Resistance to PD-1/PD-L1 Axis Blockade in KRAS-Mutant NSCLC
46. OA 12.02 Final Results of a Phase 2 Study of the hsp90 Inhibitor Luminespib (AUY922) in NSCLC Patients Harboring EGFR Exon 20 Insertions
47. OA 07.05 Serial Biopsies in Patients with EGFR-Mutant NSCLC Highlight the Spatial and Temporal Heterogeneity of Resistance Mechanisms
48. Robust Correlation between Immediate Post Radio-Chemotherapy FDG PET Response and Clinical Outcome and Impact of Salvage Radiation for Partial Metabolic Responders in Locally Advanced Non–Small Cell Lung Cancer
49. Local Control and Distant Brain Failure in Patients Treated With Concurrent Radiation and PD-1/PDL-1 Inhibitors
50. CNS Radiation-Related Adverse Events in Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.